As Managing Director of the Methuselah Fund, Sergio Ruiz has several years of experience discovering, analyzing, vetting and propelling longevity biotechnologies that can move the needle in the mission to increase the healthy human healthspan. He is also an entrepreneur-investor with a positive hands-on approach to investing who prides himself in helping with the incubation and formation of young academic teams and developing them into successful industry leaders. He currently holds several senior advisory roles for longevity biotechs and is also the Chief Operating Officer for a Stanford-born company called Turn Biotechnologies, focusing on epigenetic resetting of the age in a cell.

© 2024 BioFutureTM. All Rights Reserved

Produced by